Helen Kim

Q: What is Helen Kim email address?

Email Helen Kim at ykim@amgen.com. This email is the most updated Helen Kim email found in 2026.

Q: How to contact Helen Kim?

To contact Helen Kim send an email to ykim@amgen.com. If you want to call Helen Kim try calling on +18054472257. (updated on November 05, 2024)

Executive Director & Head of Technology, Business Development at Amgen | Ventura County, California, United States

About Helen Kim

Helen Kim serves as the Executive Director and Head of Technology, Business Development at Amgen, where she plays a pivotal role in shaping the future of drug discovery through strategic partnerships and innovative technologies. With a robust background in global business development, Helen leads a dynamic team dedicated to identifying and evaluating cutting-edge technologies that advance therapeutic solutions for oncology, autoimmune diseases, and both small and large molecule platforms. Her expertise lies not only in the scientific aspects of drug discovery—encompassing molecular biology and protein chemistry—but also in the intricate processes of deal structuring and contract negotiation.

Under Helen's leadership, Amgen has successfully forged significant collaborations with industry leaders such as Carmot, Xencor, Immatics, CytomX, and Nuevolution, as well as prestigious academic institutions including Caltech, USC, and UCSF. Notably, her collaboration with Nuevolution culminated in a successful acquisition in 2019, underscoring her ability to drive impactful partnerships that enhance Amgen's innovative capabilities. Additionally, Helen spearheaded the launch of the Amgen Biology-Enabling Resource (AmBER) program, which serves as a critical platform for fostering collaborative research and accelerating the drug development pipeline.

Helen's strategic vision and adeptness in aligning internal and external stakeholders have been instrumental in executing high-stakes partnerships that not only bolster Amgen's research portfolio but also position the company at the forefront of biopharmaceutical innovation. Her commitment to advancing drug discovery through collaborative efforts exemplifies her leadership in the industry and her dedication to improving patient outcomes worldwide.

Helen Kim Work